Theranostics 2020; 10(17):7836-7840. doi:10.7150/thno.48022

Editorial

Interleukin-22 acts as a mitochondrial protector

Seonghwan Hwang, Dechun Feng, Bin Gao

Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Hwang S, Feng D, Gao B. Interleukin-22 acts as a mitochondrial protector. Theranostics 2020; 10(17):7836-7840. doi:10.7150/thno.48022. Available from http://www.thno.org/v10p7836.htm

File import instruction

Abstract

Interleukin (IL)-22 has been increasingly recognized as a promising therapeutic option for various types of diseases. This commentary summarizes the novel mechanistic aspects of IL-22 for the treatment of liver diseases including the study by Chen et al. published in the recent issue of the Theranostics that elucidated the novel function of IL-22 as a mitochondrial protector for the adaptive defense against liver injury.

Keywords: Interleukin (IL)-22, mitochondrial protector